Identification of a novel porcine OASL variant exhibiting antiviral activity

Virus Res. 2018 Jan 15:244:199-207. doi: 10.1016/j.virusres.2017.11.013. Epub 2017 Nov 16.

Abstract

2', 5'-Oligoadenylate synthetase-lilke (OASL) protein is an atypical oligoadenylate synthetase (OAS) family member, which possesses antiviral activity but lacks 2', 5'-oligoadenylate synthetase activity. Here, a novel variant of porcine OASL (pOASL2) was identified through RT-PCR amplification. This gene is distinguishable from the previously described wild-type porcine OASL (pOASL1). The gene appears to be derived from a truncation of exon 4 plus 8 nucleotides of exon 5 with a premature termination, measuring only 633 bp in length, although its position corresponds to that of pOASL1. Given this novel gene appears to be a variant of pOASL, we assayed for antiviral activity of the protein. We demonstrated that pOASL2 could inhibit Japanese encephalitis virus (JEV) proliferation as well as pOASL1 in a transient overexpression assay of pOASL1 and pOASL2 in PK-15 and Vero cells. In addition to JEV, pOASL1 and pOASL2 also decreased the proliferations of Porcine reproductive and respiratory syndrome virus (PRRSV) and vesicular stomatitis virus (VSV), but did not exhibit antiviral activity against pseudorabies virus (PRV). Structural analysis showed that the pOASL2 gene retained only the first three exons at the 5'-. To investigate the role of the αN4 helix in pOASL in antiviral responses like that in hOASL, we mutated key residues in the anchor domain of the αN4 helix in pOASL2, based on the domain's location in hOASL. However, the antiviral activity of pOASL2 was not affected. Thus, the αN4 helix of pOASL likely does not play a significant role in its antiviral activity. In conclusion, pOASL2 acts as a new splice isoform of pOASL that plays a role in resistance to infection of several kinds of RNA viruses.

Keywords: Alternative splicing; Antiviral activity; Japanese encephalitis virus; OASL; Porcine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2',5'-Oligoadenylate Synthetase / biosynthesis
  • 2',5'-Oligoadenylate Synthetase / chemistry
  • 2',5'-Oligoadenylate Synthetase / genetics
  • 2',5'-Oligoadenylate Synthetase / pharmacology*
  • Alternative Splicing*
  • Amino Acid Sequence
  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Cell Line
  • Chlorocebus aethiops
  • Encephalitis Virus, Japanese / drug effects*
  • Encephalitis Virus, Japanese / genetics
  • Encephalitis Virus, Japanese / growth & development
  • Encephalitis Virus, Japanese / metabolism
  • Epithelial Cells / drug effects
  • Epithelial Cells / pathology
  • Epithelial Cells / virology
  • Exons
  • Herpesvirus 1, Suid / drug effects
  • Herpesvirus 1, Suid / genetics
  • Herpesvirus 1, Suid / growth & development
  • Herpesvirus 1, Suid / metabolism
  • Isoenzymes / biosynthesis
  • Isoenzymes / chemistry
  • Isoenzymes / genetics
  • Isoenzymes / pharmacology
  • Kidney / drug effects
  • Kidney / pathology
  • Kidney / virology
  • Open Reading Frames
  • Porcine respiratory and reproductive syndrome virus / drug effects*
  • Porcine respiratory and reproductive syndrome virus / genetics
  • Porcine respiratory and reproductive syndrome virus / growth & development
  • Porcine respiratory and reproductive syndrome virus / metabolism
  • Protein Conformation, alpha-Helical
  • Protein Interaction Domains and Motifs
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Swine
  • Vero Cells
  • Vesiculovirus / drug effects*
  • Vesiculovirus / genetics
  • Vesiculovirus / growth & development
  • Vesiculovirus / metabolism

Substances

  • Antiviral Agents
  • Isoenzymes
  • 2',5'-Oligoadenylate Synthetase